The metabolic syndrome in patients with chronic obstructive pulmonary disease

A. A. Daouud, A. Khoury, L. Shakerdi (Aleppo, Syrian Arab Republic)

Source: International Congress 2014 – The assessment of comorbidities
Session: The assessment of comorbidities
Session type: Thematic Poster Session
Number: 979
Disease area: Airway diseases, Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. A. Daouud, A. Khoury, L. Shakerdi (Aleppo, Syrian Arab Republic). The metabolic syndrome in patients with chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 979

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Abdulla Khouri - 17.09.2014 17:50
A wondefull study regarding the civil war in SYRIA.
Many thanks for The ERS scientific committe

Mats Arne (Karlstad, Sweden) - 09.09.2014 21:25
Brilliant poster!
You must Login to comment this presentation.


Related content which might interest you:
Chronic obstructive pulmonary disease (COPD) and alterations of hemogram
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Adipokines and ghrelin in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Diabetes mellitus and obstructive pulmonary disease. Is there an association?
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014

Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Metabolic syndrome in chronic obstructive pulmonary disease
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018

Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014


Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013

Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study
Source: Eur Respir J 2012; 39: 846-854
Year: 2012



Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009